Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind …
AF Romano-Munive… - BMJ Open …, 2021 - bmjopengastro.bmj.com
Background and study aims Post-endoscopic retrograde cholangiopancreatography (ERCP)
pancreatitis (PEP) is a complication associated with important morbidity, occasional mortality …
pancreatitis (PEP) is a complication associated with important morbidity, occasional mortality …
[HTML][HTML] Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind …
AF Romano-Munive, JJ García-Correa… - BMJ Open …, 2021 - ncbi.nlm.nih.gov
Results Of the 3602 patients deemed eligible, 3054 were excluded after screening. The
remaining 548 patients were randomised to EI group (n= 275) or WI group (n= 273). The EI …
remaining 548 patients were randomised to EI group (n= 275) or WI group (n= 273). The EI …
Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind …
AF Romano-Munive, JJ García-Correa… - 2021 - pubmed.ncbi.nlm.nih.gov
Background and study aims Post-endoscopic retrograde cholangiopancreatography (ERCP)
pancreatitis (PEP) is a complication associated with important morbidity, occasional mortality …
pancreatitis (PEP) is a complication associated with important morbidity, occasional mortality …
Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind …
AF Romano-Munive, JJ García-Correa… - BMJ Open …, 2021 - europepmc.org
Results Of the 3602 patients deemed eligible, 3054 were excluded after screening. The
remaining 548 patients were randomised to EI group (n= 275) or WI group (n= 273). The EI …
remaining 548 patients were randomised to EI group (n= 275) or WI group (n= 273). The EI …